Test Price
2,800 AED✅ Home Collection Available
TPI1 Gene Triosephosphate Isomerase Deficiency Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين TPI1 لنقص تريوز فوسفات إيزوميراز في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain, VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي
يوفر اختبار جين TPI1 بتقنية التسلسل الجيني من الجيل التالي (NGS) تشخيصاً دقيقاً لنقص إنزيم تريوز فوسفات إيزوميراز، وهو اضطراب استقلابي وراثي نادر يتميز بفقر الدم الانحلالي واضطرابات عصبية عضلية. نضمن دقة تشخيصية تصل إلى 99.9% وفق معايير ISO 9001:2015 المعتمدة دولياً، مع خدمة سحب عينات منزلية عالية الجودة عبر نظام سلسلة تبريد معتمد، واستشارة طبية هاتفية بعد الفحص لتفسير النتائج، وإمكانية التحقق المباشر من التغطية التأمينية عبر واتساب على الرقم 971545488731+.
Overview
This advanced Next-Generation Sequencing (NGS) test comprehensively analyzes the TPI1 gene to identify pathogenic mutations responsible for Triosephosphate isomerase deficiency—a rare autosomal recessive inborn error of metabolism leading to chronic hemolytic anemia, progressive neuromuscular dysfunction, and increased susceptibility to infections. It serves as the gold standard for molecular confirmation, carrier detection, and informed family planning.
| Feature | Our Test (ISO 9001:2015) | Alternative (Enzyme Assay) |
|---|---|---|
| Methodology | Full gene NGS, covering exons & splice sites | Biochemical Triosephosphate isomerase activity in RBCs |
| Diagnostic Sensitivity | 99.9% | Variable (affected by recent transfusion) |
| Turnaround Time | 3–4 Weeks | 2–3 Weeks |
| Carrier & Prenatal Testing | Yes (definitive) | No |
Physician Insight & Safety Protocol
“I recognize that pursuing a genetic diagnosis can be emotionally challenging. This test offers definitive molecular answers, yet it is essential that findings are interpreted within the full clinical context, including symptom severity, family history, and specialist evaluation, to guide appropriate care.” — Dr. Prabhakar Reddy, DHA License 61713011
Clinical Safety & Exclusion Criteria
- Exclusion: Do not undergo testing within 2 weeks of a blood transfusion, as donor DNA may confound results.
- ER Red Flags: If you experience sudden fainting, dark urine, severe muscle weakness, or signs of aplastic crisis (e.g., pallor, heart palpitations), seek emergency medical attention immediately.
- Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Patient FAQ & Clinical Guidance
Q1: What is the TPI1 Genetic Test and who should consider it?
Direct Answer (Snippet Killer): This DNA test screens for Triosephosphate isomerase deficiency by sequencing the entire TPI1 gene, confirming mutations that cause this rare autosomal recessive disorder. It is recommended for individuals with unexplained hemolytic anemia, neuromotor delays, or a positive family history of metabolic disease, as well as for carrier screening in consanguineous families. Clinical genetic counseling is mandatory before sampling.
Q2: How is the sample collected and when will I receive my results?
Direct Answer (Snippet Killer): Our licensed mobile phlebotomists collect a small blood sample or a finger-prick FTA card at your home, fully cold‑chain compliant, and you will receive your confidential report in 3 to 4 weeks. Samples must be accompanied by a detailed clinical history and a pedigree chart from a prior genetic counseling session to ensure accurate interpretation. Same‑day collection is available in all UAE emirates until 11 PM, including weekends.
Q3: Is the covered by UAE health insurance and what are my rights under the new data law?
Direct Answer (Snippet Killer): Many leading UAE insurers reimburse genetic testing for specific clinical indications; our team will verify your coverage upon receiving your policy details via WhatsApp. All personal health data is processed in strict accordance with the UAE Personal Data Protection Law (PDPL) and Federal Decree-Law No. 41 of 2024, ensuring your genetic information remains confidential and used only for diagnostic purposes.
UAE Regulatory Compliance: This diagnostic service adheres to Federal Decree-Law No. 41 of 2024 (Article 87) on the Prevention of Communicable Diseases, the 2026 CDS Law regarding minors’ data, and the UAE Personal Data Protection Law. Our laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and operates under DHA/MOHAP facility license 9834453.
Medical Coding: LOINC 81232-6 (View LOINC), ICD-10-CM D55.2, E74.8, Z13.8. Method: NGS (Next Generation Sequencing) – Liquid Biopsy Grade DNA extraction and library preparation.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians